Provided herein is a combination therapy comprising an mTOR inhibitor and a JAK inhibitor. The combination therapy is useful for the treatment of a variety of cancers, including MPNs. The combination therapy is also useful for the treatment of any number of JAK-associated diseases.

mTOR/JAK INHIBITOR COMBINATION THERAPY / A.M. VANNUCCHI; C. BOGANI; P. GUGLIELMELLI; NOVARTIS PHARMA AG; INCYTE CORP.. - (2012).

mTOR/JAK INHIBITOR COMBINATION THERAPY

VANNUCCHI, ALESSANDRO MARIA;BOGANI, COSTANZA;GUGLIELMELLI, PAOLA;
2012

Abstract

Provided herein is a combination therapy comprising an mTOR inhibitor and a JAK inhibitor. The combination therapy is useful for the treatment of a variety of cancers, including MPNs. The combination therapy is also useful for the treatment of any number of JAK-associated diseases.
2012
A.M. VANNUCCHI; C. BOGANI; P. GUGLIELMELLI; NOVARTIS PHARMA AG; INCYTE CORP.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/602011
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact